Thymic stromal lymphopoietin levels after allogeneic hematopoietic stem cell transplantation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Background: Thymic stromal lymphopoietin (TSLP) is an immunoregulatory, Th2-polarizing cytokine produced by epithelial cells. We hypothesized that TSLP affects immune reconstitution after hematopoietic stem cell transplantation (HSCT) leading to increased alloreactivity. Methods: We measured plasma TSLP by ELISA in 38 patients and assessed the immune reconstitution by flow cytometry. Results: TSLP levels rose after initiation of the conditioning to peak at day +21 after HSCT (p =.03), where TSLP levels correlated with counts of neutrophils (rho = 0.36, p =.04), monocytes (rho = 0.58, p =.006), and lymphocytes (rho = 0.59, p =.02). Overall absolute TSLP levels were not associated with acute or chronic graft-vs-host disease (a/cGvHD). However, patients mounting a sustained increase in TSLP levels at day +90 had a higher risk of cGvHD compared to patients who had returned to pre-conditioning levels at that stage (cumulative incidence: 77% vs. 38%, p =.01). Conclusion: In conclusion, this study suggests a role of TSLP in immune reconstitution and alloreactivity post-HSCT. lymphopoietin (TSLP) is an immunoregulatory, Th2-polarizing cytokine produced by epithelial cells. We hypothesized that TSLP affects immune reconstitution after hematopoietic stem cell transplantation (HSCT) leading to increased alloreactivity. We measured plasma TSLP by ELISA in 38 patients and assessed the immune reconstitution by flow cytometry.

OriginalsprogEngelsk
TidsskriftImmunopharmacology and Immunotoxicology
Vol/bind44
Udgave nummer6
Sider (fra-til)1004-1012
Antal sider9
ISSN0892-3973
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
DLM: Received a grant from the Research Council at Rigshospitalet; KK: Received a grant from Åse og Ejner Danielsens Fond. CHN, HS, AEP, LPR, and KM reported no conflict of interest.

Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.

ID: 316065097